Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
LB Pharmaceuticals, Inc. ( (LBRX) ) has provided an update.
On November 10, 2025, LB Pharmaceuticals Inc. amended its lease agreement with One Penn Plaza LLC to include an additional 4,634 square feet on the 10th floor of One Penn Plaza, New York. The lease term is set to expire on March 31, 2032, with the expansion premises expected to be delivered by July 1, 2026. The initial fixed rent for the expansion will be $430,962 annually for the first three years, increasing to $477,302 thereafter, with a rent abatement period agreed upon for the first 150 days.
The most recent analyst rating on (LBRX) stock is a Buy with a $27.00 price target. To see the full list of analyst forecasts on LB Pharmaceuticals, Inc. stock, see the LBRX Stock Forecast page.
More about LB Pharmaceuticals, Inc.
Average Trading Volume: 241,707
For detailed information about LBRX stock, go to TipRanks’ Stock Analysis page.